List of works - Jürg Oliver Straub

A risk-based approach to managing active pharmaceutical ingredients in manufacturing effluent.

scientific article published on 16 July 2015

A strategy to reduce the numbers of fish used in acute ecotoxicity testing of pharmaceuticals.

scientific article published in December 2003

An Environmental Risk Assessment for Human-Use Trimethoprim in European Surface Waters

scientific article published on 18 March 2013

Aquatic environmental risk assessment for human use of the old antibiotic sulfamethoxazole in Europe

scientific article

Combined environmental risk assessment for 5-fluorouracil and capecitabine in Europe.

scientific article published in July 2010

Combined environmental risk assessment for the antiviral pharmaceuticals ganciclovir and valganciclovir in Europe.

scientific article published on 15 February 2017

Coral gardener of the Maldives.

scientific article published in April 2002

Deterministic and probabilistic acute-based environmental risk assessment for naproxen for western Europe

scientific article published on 01 April 2007

Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters

scientific article published on 19 September 2019

Environmental risk assessment for ancillary substances in biotechnological production of pharmaceuticals

scientific article

Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001

scientific article published on 01 October 2002

Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate

scientific article published on 09 October 2018

Environmental risk assessment of metformin and its transformation product guanylurea: II. Occurrence in surface waters of Europe and the United States and derivation of predicted no-effect concentrations

scientific article published on 15 October 2018

Exploiting monitoring data in environmental exposure modelling and risk assessment of pharmaceuticals.

scientific article

Extending the environmental risk assessment for oseltamivir (Tamiflu) under pandemic use conditions to the coastal marine compartment.

scientific article

Meeting report: risk assessment of tamiflu use under pandemic conditions.

scientific article

Mixture toxicity of the antiviral drug Tamiflu((R)) (oseltamivir ethylester) and its active metabolite oseltamivir acid

scientific article published in November 2009

Performance of an anaerobic membrane bioreactor for pharmaceutical wastewater treatment.

scientific article published on 13 January 2017

Pharmaceuticals and personal care products in the environment: what are the big questions?

scientific article

Rational selection of alternative, environmentally compatible surfactants for biotechnological production of pharmaceuticals--a step toward green biotechnology.

scientific article published on August 2014

Recommendations on the environmental risk assessment of pharmaceuticals: Effect characterization

scientific article published in July 2010

Science-based Targets for Antibiotics in Receiving Waters from Pharmaceutical Manufacturing Operations

scientific article published on 01 May 2019

Use of acute and chronic ecotoxicity data in environmental risk assessment of pharmaceuticals

scientific article published on 25 September 2015

List of works by Jürg Oliver Straub

A risk-based approach to managing active pharmaceutical ingredients in manufacturing effluent.

A strategy to reduce the numbers of fish used in acute ecotoxicity testing of pharmaceuticals.

An Environmental Risk Assessment for Human-Use Trimethoprim in European Surface Waters

Aquatic environmental risk assessment for human use of the old antibiotic sulfamethoxazole in Europe

Combined environmental risk assessment for 5-fluorouracil and capecitabine in Europe.

Combined environmental risk assessment for the antiviral pharmaceuticals ganciclovir and valganciclovir in Europe.

Coral gardener of the Maldives.

Deterministic and probabilistic acute-based environmental risk assessment for naproxen for western Europe

Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters

Environmental risk assessment for ancillary substances in biotechnological production of pharmaceuticals

Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001

Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate

Environmental risk assessment of metformin and its transformation product guanylurea: II. Occurrence in surface waters of Europe and the United States and derivation of predicted no-effect concentrations

Exploiting monitoring data in environmental exposure modelling and risk assessment of pharmaceuticals.

Extending the environmental risk assessment for oseltamivir (Tamiflu) under pandemic use conditions to the coastal marine compartment.

Meeting report: risk assessment of tamiflu use under pandemic conditions.

Mixture toxicity of the antiviral drug Tamiflu((R)) (oseltamivir ethylester) and its active metabolite oseltamivir acid

Performance of an anaerobic membrane bioreactor for pharmaceutical wastewater treatment.

Pharmaceuticals and personal care products in the environment: what are the big questions?

Rational selection of alternative, environmentally compatible surfactants for biotechnological production of pharmaceuticals--a step toward green biotechnology.

Recommendations on the environmental risk assessment of pharmaceuticals: Effect characterization

Science-based Targets for Antibiotics in Receiving Waters from Pharmaceutical Manufacturing Operations

Use of acute and chronic ecotoxicity data in environmental risk assessment of pharmaceuticals